Header Logo

Connection

Pankaj Singh to Carcinoma, Pancreatic Ductal

Back to Details
This is a "connection" page, showing publications Pankaj Singh has written about Carcinoma, Pancreatic Ductal.
Pankaj Singh
Connection Strength
3.437
Carcinoma, Pancreatic Ductal
  1. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
    View in: PubMed
    Score: 0.614
  2. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. Methods Mol Biol. 2018; 1742:95-105.
    View in: PubMed
    Score: 0.481
  3. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Lett. 2017 08 01; 400:37-46.
    View in: PubMed
    Score: 0.459
  4. Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma. Nat Commun. 2025 Dec 31; 17(1):1343.
    View in: PubMed
    Score: 0.209
  5. A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection. ACS Nano. 2025 Dec 23; 19(50):42056-42065.
    View in: PubMed
    Score: 0.209
  6. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Res. 2022 06 15; 82(12):2254-2268.
    View in: PubMed
    Score: 0.164
  7. The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells. Nucleic Acids Res. 2022 04 08; 50(6):3394-3412.
    View in: PubMed
    Score: 0.162
  8. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.
    View in: PubMed
    Score: 0.160
  9. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 12; 20(12):2457-2468.
    View in: PubMed
    Score: 0.156
  10. The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Mol Cancer Ther. 2021 11; 20(11):2166-2176.
    View in: PubMed
    Score: 0.155
  11. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. Gastroenterology. 2020 11; 159(5):1866-1881.e8.
    View in: PubMed
    Score: 0.144
  12. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188387.
    View in: PubMed
    Score: 0.143
  13. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
    View in: PubMed
    Score: 0.117
  14. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2016 Jan 11; 17(1):301-13.
    View in: PubMed
    Score: 0.104
  15. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clin Cancer Res. 2012 Nov 15; 18(22):6188-98.
    View in: PubMed
    Score: 0.083
  16. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin Cancer Res. 2011 Oct 01; 17(19):6140-50.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.